Functional alterations in protein kinase C beta II expression in melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 2, 2010, Pages 216-224

  Voris, John P ^a   Sitailo, Leonid A ^a   Rahn, Heidi R ^a   Defnet, Ann ^b   Gerds, Aaron T ^b   Sprague, Robert ^b   Yadav, Vipin ^a   Caroline Le Poole, I ^a,b   Denning, Mitchell F ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Melanocyte; Melanoma; Mitochondria; PKC; Reactive oxygen species; UV radiation

Indexed keywords

AGAR; MELANIN; MESSENGER RNA; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C BETA 2; PROTEIN KINASE C IOTA; PROTEIN KINASE C ZETA; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; SOFT AGAR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E6; VIRUS PROTEIN E7;

ARTICLE; CANCER CELL CULTURE; CELL IMMORTALIZATION; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MELANOCYTE; MELANOGENESIS; MELANOMA; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR GROWTH; ULTRAVIOLET RADIATION;

CELL LINE; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; OXIDATIVE STRESS; PHENOTYPE; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 77949350426     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00664.x     Document Type: Article

References (49)

1. Arita, Y., O'Driscoll, K.R., and Weinstein, I.B. (1992). Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res. 52, 4514-4521.
2. Arita, Y., O'Driscoll, K.R., and Weinstein, I.B. (1994). Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate. Int. J. Cancer 56, 229-235.
3. Becker, K.P., and Hannun, Y.A. (2004). Isoenzyme-specific translocation of protein kinase C (PKC)βII and not PKCβI to a juxtanuclear subset of recycling endosomes: involvement of phospholipase D. J. Biol. Chem. 279, 28251-28256.
4. Becker, D., Beebe, S.J., and Herlyn, M. (1990). Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. Oncogene 5, 1133-1139.
5. Brooks, G., Birch, M., and Hart, I.R. (1990). Effects of biologically active tumour-promoting and non-promoting phorbol esters on in vitro growth of melanocytic cells. Pigment Cell Res. 3, 98-100.
6. Cejas, P.J., Carlson, L.M., Zhang, J., Padmanabhan, S., Kolonias, D., Lindner, I., Haley, S., Boise, L.H., and Lee, K.P. (2005). Protein kinase C βII plays an essential role in dendritic cell differentiation and autoregulates its own expression. J. Biol. Chem. 280, 28412-28423.
7. Chien, A.J., Moore, E.C., Lonsdorf, A.S., Kulikauskas, R.M., Rothberg, B.G., Berger, A.J., Major, M.B., Hwang, S.T., Rimm, D.L., and Moon, R.T. (2009). Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc. Natl. Acad. Sci. U S A 106, 1193-1198.
8. D'Costa, A.M., and Denning, M.F. (2005). A caspase-resistant mutant of PKC-δ protects keratinocytes from UV-induced apoptosis. Cell Death Differ. 12, 224-232.
9. DelCarlo, M., and Loeser, R.F. (2006). Chondrocyte cell death mediated by reactive oxygen species-dependent activation of PKC-βI. Am. J. Physiol. Cell Physiol. 290, C802-C811.
10. Denning, M.F., Wang, Y., Nickoloff, B.J., and Wrone-Smith, T. (1998). Protein kinase Cδ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273, 29995-30002.
11. Dissanayake, S.K., Olkhanud, P.B., O'Connell, M.P. et al. (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res. 68, 10205-10214.
12. Eisinger, M., and Marko, O. (1982). Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. U S A 79, 2018-2022.
13. Fridberg, M., Servin, A., Anagnostaki, L. et al. (2007). Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-β II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk. Lymphoma 48, 2221-2232.
14. Gilhooly, E.M., Morse-Gaudio, M., Bianchi, L., Reinhart, L., Rose, D.P., Connolly, J.M., Reed, J.A., and Albino, A.P. (2001). Loss of expression of protein kinase C β is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Melanoma Res. 11, 355-369.
15. Gonindard, C., Bergonzi, C., Denier, C., Sergheraert, C., Klaebe, A., Chavant, L., and Hollande, E. (1997). Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol. Toxicol. 13, 141-153.
16. Govindarajan, B., Sligh, J.E., Vincent, B.J. et al. (2007). Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J. Clin. Invest. 117, 719-729.
17. Halaban, R., Ghosh, S., Duray, P., Kirkwood, J.M., and Lerner, A.B. (1986). Human melanocytes cultured from nevi and melanomas. J. Invest. Dermatol. 87, 95-101.
18. Hoek, K., Rimm, D.L., Williams, K.R. et al. (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 64, 5270-5282.
19. Krasagakis, K., Lindschau, C., Fimmel, S., Eberle, J., Quass, P., Haller, H., and Orfanos, C.E. (2004). Proliferation of human melanoma cells is under tight control of protein kinase C alpha. J. Cell Physiol. 199, 381-387.
20. Le Poole, I.C., van den Berg, F.M., van den Wijngaard, R.M., Galloway, D.A., van Amstel, P.J., Buffing, A.A., Smits, H.L., Westerhof, W., and Das, P.K. (1997). Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell Dev. Biol. Anim. 33, 42-49.
21. Leikam, C., Hufnagel, A., Schartl, M., and Meierjohann, S. (2008). Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 27, 7070-7082.
22. Liliental, J., and Chang, D.D. (1998). Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J. Biol. Chem. 273, 2379-2383.
23. Lopez-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L.H., and Ronai, Z. (2005). Receptor for RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19, 309-320.
24. Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447-460.
25. Lorigan, P., Eisen, T., and Hauschild, A. (2008). Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future? Exp. Dermatol. 17, 383-394.
26. Moiseeva, O., Bourdeau, V., Roux, A., Deschenes-Simard, X., and Ferbeyre, G. (2009). Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol. Cell. Biol. 29, 4495-4507.
27. Niino, Y.S., Ohno, S., and Suzuki, K. (1992). Positive and negative regulation of the transcription of the human protein kinase C β gene. J. Biol. Chem. 267, 6158-6163.
28. Obeid, L.M., Blobe, G.C., Karolak, L.A., and Hannun, Y.A. (1992). Cloning and characterization of the major promoter of the human protein kinase C β gene. Regulation by phorbol esters. J. Biol. Chem. 267, 20804-20810.
29. Oka, M., Nishigori, C., Kageshita, T., Hsu, M.Y., Penmatcha, S., and Herlyn, M. (2006). Expression of PKC isoforms in human melanocytic cells in situ. J. Dermatol. Sci. 41, 157-161.
30. Oka, M., Kikkawa, U., and Nishigori, C. (2008). Protein kinase C-βII represses hepatocyte growth factor-induced invasion by preventing the association of adapter protein Gab1 and phosphatidylinositol 3-kinase in melanoma cells. J. Invest. Dermatol. 128, 188-195.
31. Ono, Y., Kurokawa, T., Fujii, T., Kawahara, K., Igarashi, K., Kikkawa, U., Ogita, K., and Nishizuka, Y. (1986). Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing. FEBS Lett. 206, 347-352.
32. Park, H.Y., Russakovsky, V., Ohno, S., and Gilchrest, B.A. (1993). The β isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J. Biol. Chem. 268, 11742-11749.
33. Park, H.Y., Perez, J.M., Laursen, R., Hara, M., and Gilchrest, B.A. (1999). Protein kinase C-β activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J. Biol. Chem. 274, 16470-16478.
34. Park, H.Y., Lee, J., Gonzalez, S., Middelkamp-Hup, M.A., Kapasi, S., Peterson, S., and Gilchrest, B.A. (2004a). Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J. Invest. Dermatol. 122, 159-166.
35. Park, H.Y., Wu, H., Killoran, C.E., and Gilchrest, B.A. (2004b). The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-β on melanosomes. J. Cell Sci. 117, 3659-3668.
36. Parker, P.J., and Murray-Rust, J. (2004). PKC at a glance. J. Cell Sci. 117, 131-132.
37. Patel, N.A., Chalfant, C.E., Yamamoto, M., Watson, J.E., Eichler, D.C., and Cooper, D.R. (1999). Acute hyperglycemia regulates transcription and posttranscriptional stability of PKCβII mRNA in vascular smooth muscle cells. FASEB J. 13, 103-113.
38. Pinton, P., Rimessi, A., Marchi, S. et al. (2007). Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the lifespan determinant p66Shc. Science 315, 659-663.
39. Powell, M.B., Rosenberg, R.K., Graham, M.J., Birch, M.L., Yamanishi, D.T., Buckmeier, J.A., and Meyskens Jr, F.L. (1993). Protein kinase C β expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate. J. Cancer Res. Clin. Oncol. 119, 199-206.
40. Ryu, B., Kim, D.S., Deluca, A.M., and Alani, R.M. (2007). Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE 2, e594.
41. Sander, C.S., Chang, H., Hamm, F., Elsner, P., and Thiele, J.J. (2004). Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 43, 326-335.
42. Sanz-Navares, E., Fernandez, N., Kazanietz, M.G., and Rotenberg, S.A. (2001). Atypical protein kinase Cζ suppresses migration of mouse melanoma cells. Cell Growth Differ. 12, 517-524.
43. Scott, G.A., Arioka, M., and Jacobs, S.E. (2007). Lysophosphatidylcholine mediates melanocyte dendricity through PKCζ activation. J. Invest. Dermatol. 127, 668-675.
44. Selzer, E., Okamoto, I., Lucas, T., Kodym, R., Pehamberger, H., and Jansen, B. (2002). Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res. 12, 201-209.
45. Stavroulaki, M., Kardassis, D., Chatzaki, E., Sakellaris, G., Lindschau, C., Haller, H., Tosca, A., and Krasagakis, K. (2008). Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor β. J. Cell. Physiol. 214, 363-370.
46. Stebbins, E.G., and Mochly-Rosen, D. (2001). Binding specificity for RACK1 resides in the V5 region of βII protein kinase C. J. Biol. Chem. 276, 29644-29650.
47. Stennett, L.S., Riker, A.I., Kroll, T.M., ChaMberlin, J., Miki, T., Nickoloff, B.J., and Le Poole, I.C. (2004). Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region. Pigment Cell Res. 17, 525-532.
48. Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
49. V599EB- RAF is an oncogene in melanocytes. Cancer Res. 64, 2338-2342.